Product Information

THEOPHYLLINE ER 450 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $1.1410 per EA under NDC 64380024401. Its NADAC has been published 88 times since Mar 19, 2025.

FDA first approved this application on Sep 5, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

THEOPHYLLINE ER 450 MG TABLET

Theophylline
$1.1410per EA

Strength

450 mg/1

NDC

64380024401

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

THEOPHYLLINE ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA215312

FDA Approved

9/5/2024

TE Code

AB

On Market Since

9/27/2024

Pharmacological Classes

Price Statistics

The NADAC for THEOPHYLLINE ER 450 MG TABLET has been published 88 times since Mar 19, 2025, and over the history we have for it it has declined 40.4%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1410 per EA
All-time high$1.9133 (Apr 16, 2025)
All-time low$0.5902 (Nov 19, 2025)
52-week high$1.1638
52-week low$0.5902
Median price$1.0974
Average price$1.1533
Largest weekly change+45.0% (Dec 17, 2025)
Weeks tracked88
Tracking sinceMar 19, 2025

Price History

1W

+2.5%

1M

+3.8%

3M

+8.6%

6M

+12.1%

1Y

+72.3%

3Y

N/A

5Y

N/A

All

-40.4%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of THEOPHYLLINE ER 450 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for THEOPHYLLINE ER 450 MG TABLET, manufactured by Strides Pharma Inc., is $1.1410 per EA (NDC 64380024401), effective Nov 18, 2026.

How has the price of THEOPHYLLINE ER 450 MG TABLET changed over time?

Over the history we have for it, the NADAC for THEOPHYLLINE ER 450 MG TABLET has declined 40.4%. It has been tracked across 88 weekly CMS publications since Mar 19, 2025.

What are the highest and lowest recorded NADAC prices for THEOPHYLLINE ER 450 MG TABLET?

Since Mar 19, 2025, the NADAC for THEOPHYLLINE ER 450 MG TABLET has ranged from a low of $0.5902 (Nov 19, 2025) to a high of $1.9133 (Apr 16, 2025), with a median of $1.0974 per EA.

Are there cheaper alternatives to THEOPHYLLINE ER 450 MG TABLET?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, THEOPHYLLINE ER 450 MG TABLET, is $1.1149 per EA — about 2% below THEOPHYLLINE ER 450 MG TABLET.

Who manufactures THEOPHYLLINE ER 450 MG TABLET?

THEOPHYLLINE ER 450 MG TABLET (NDC 64380024401) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.